We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$27.8B
AUM Growth
+$2.54B
Cap. Flow
+$477M
Cap. Flow %
1.71%
Top 10 Hldgs %
17.19%
Holding
2,397
New
92
Increased
1,264
Reduced
960
Closed
73

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$37.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$35.5M
3
VZ icon
Verizon
VZ
+$26.4M
4
TFC icon
Truist Financial
TFC
+$26.1M
5
CTXS
Citrix Systems Inc
CTXS
+$18.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$53.1M
2
STI
SunTrust Banks, Inc.
STI
+$25.3M
3
CHL
China Mobile Limited
CHL
+$16.9M
4
CUK
Carnival PLC
CUK
+$15M
5
WBK
Westpac Banking Corporation
WBK
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 20.1%
2 Financials 16.78%
3 Healthcare 13.34%
4 Consumer Discretionary 9.48%
5 Communication Services 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTES icon
1326
Gates Industrial Corporation Ltd.
GTES
$7.08B
$1.22M ﹤0.01%
88,684
-19,134
-18% -$218K
BGS icon
1327
B&G Foods
BGS
$287M
$1.22M ﹤0.01%
67,974
+23,305
+52% +$392K
MSA icon
1328
Mine Safety
MSA
$7.35B
$1.22M ﹤0.01%
9,622
-1,401
-13% -$169K
UMBF icon
1329
UMB Financial
UMBF
$11.1B
$1.21M ﹤0.01%
17,686
+2,352
+15% +$156K
IONS icon
1330
Ionis Pharmaceuticals
IONS
$8.6B
$1.21M ﹤0.01%
20,076
-2,459
-11% -$147K
OPLN
1331
Openlane
OPLN
$4.21B
$1.21M ﹤0.01%
55,685
-22,349
-29% -$510K
OI icon
1332
O-I Glass
OI
$1.1B
$1.21M ﹤0.01%
101,648
+36,483
+56% +$364K
SCL icon
1333
Stepan Co
SCL
$1.46B
$1.21M ﹤0.01%
11,837
+220
+2% +$21.4K
PRGS icon
1334
Progress Software
PRGS
$1.66B
$1.21M ﹤0.01%
29,149
-1,337
-4% -$54.3K
SEM
1335
DELISTED
Select Medical
SEM
$1.21M ﹤0.01%
96,323
+3,820
+4% +$41.1K
HTGC icon
1336
Hercules Capital
HTGC
$3.07B
$1.21M ﹤0.01%
86,215
+15,118
+21% +$210K
ARGO
1337
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$1.21M ﹤0.01%
18,388
+1,500
+9% +$98.1K
CXT icon
1338
Crane NXT
CXT
$2.99B
$1.21M ﹤0.01%
40,199
+961
+2% +$27.4K
EGHT icon
1339
8x8 Inc
EGHT
$269M
$1.21M ﹤0.01%
65,863
-5,155
-7% -$99.5K
WGO icon
1340
Winnebago Industries
WGO
$856M
$1.2M ﹤0.01%
22,646
+272
+1% +$12.7K
STMP
1341
DELISTED
Stamps.com, Inc.
STMP
$1.2M ﹤0.01%
14,340
+145
+1% +$12.1K
CYD icon
1342
China Yuchai International
CYD
$1.77B
$1.2M ﹤0.01%
89,830
+12,032
+15% +$162K
ACAD icon
1343
Acadia Pharmaceuticals
ACAD
$4.43B
$1.2M ﹤0.01%
27,953
+3,385
+14% +$147K
NEO icon
1344
NeoGenomics
NEO
$1.96B
$1.2M ﹤0.01%
40,885
-726
-2% -$17.3K
NVCR icon
1345
NovoCure
NVCR
$1.73B
$1.2M ﹤0.01%
14,185
+252
+2% +$20.3K
INVX
1346
Innovex International
INVX
$1.96B
$1.2M ﹤0.01%
25,466
-3,825
-13% -$175K
SPSC icon
1347
SPS Commerce
SPSC
$2.64B
$1.19M ﹤0.01%
21,420
-4,128
-16% -$219K
BKE icon
1348
Buckle
BKE
$2.25B
$1.19M ﹤0.01%
43,869
+1,682
+4% +$40K
CPA icon
1349
Copa Holdings
CPA
$5.76B
$1.18M ﹤0.01%
10,955
+1,513
+16% +$158K
ZG icon
1350
Zillow
ZG
$7.94B
$1.18M ﹤0.01%
25,829
-6,342
-20% -$234K
52 53
54
55 56

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q4 2019 Portfolio in Review

As of Q4 2019, Aperio Group held 2,397 positions worth $27.8B, up 10% from $25.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Aperio Group's Q4 2019 filing shows 92 new, 1,264 increased, 960 reduced and 73 closed positions. Its largest new stake was Cerence: 67,887 shares worth $1.54M. The largest sale was Celgene Corp, an estimated $53.1M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2019 buy was Cerence: 67,887 shares worth $1.54M.
  • Aperio Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $37.3M increase.
  • Aperio Group's biggest Q4 2019 reduction was China Mobile Limited, cutting an estimated $16.9M.
  • Aperio Group fully exited Celgene Corp in Q4 2019, selling an estimated $53.1M.
  • Aperio Group's ten largest holdings make up 17% of its $27.8B portfolio in Q4 2019.
  • Aperio Group opened 92 new positions and closed 73 in Q4 2019.
  • Aperio Group's portfolio value rose 10% quarter-over-quarter to $27.8B.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.